Patents for A61P 17 - Drugs for dermatological disorders (106,455)
09/2009
09/03/2009US20090220450 Methods and compositions for wound healing
09/03/2009US20090220444 Antiperspirant and Deodorant Compositions with Improved Protective Action
09/03/2009US20090218731 Shaped body and method for production of said body
09/03/2009US20090217924 Treatment systems and methods
09/03/2009CA2716400A1 Method for increasing the activity of the immune system of a mammal at risk of inflammatory diseases
09/03/2009CA2716336A1 Pyridazine derivatives and their use as therapeutic agents in the treatment of skin disorders
09/03/2009CA2716316A1 Methods of modulating the activity of the mc5 receptor and treatment of conditions related to this receptor
09/03/2009CA2716256A1 3-substituted-1,4-diazepan-2-one melanocortin-5 receptor antagonists
09/03/2009CA2716250A1 3-aminoalkyl-1,4-diazepan-2-one melanocortin-5 receptor antagonists
09/03/2009CA2714721A1 Anti-allergic agent
09/03/2009CA2713776A1 New macrolides and their use
09/03/2009CA2620242A1 Topical soothing bruise healing preparation
09/02/2009EP2095820A1 Fermented milk for improving and/or treating skin and method for producing the same
09/02/2009EP2094289A1 Conjoint therapy for treating fibrotic diseases
09/02/2009EP2094286A2 Compositions and methods of inducing hair growth utilizing continus coggygria
09/02/2009EP2094277A1 A composition for treatment of atopic dermatitis comprising glucosamine and derivatives thereof and a method for treatment of atopic dermatitis using them
09/02/2009EP2094271A2 Drug combinations for treating airway diseases
09/02/2009EP1957098B1 Management of non septic patients suffering from partial thickness burns by administration of activated protein c
09/02/2009EP1496890B1 Substituted beta-aminoalcohols used as medicaments
09/02/2009EP1478365B1 Combination consisting of trapidil and 5ht2-serotonin antagonists such as cyproheptadine or pizotifen for inhibiting angiogenesis
09/02/2009EP1470137B1 Edg receptor agonists
09/02/2009EP1458392B1 Acridones as inhibitors of impdh enzyme
09/02/2009EP1411913A4 Antimicrobial nanoemulsion compositions and methods
09/02/2009EP1392349B1 Use of angiotensinogen and its derivatives for manufacturing anti-angiogenesis pharmaceutical compositions
09/02/2009EP1276483B1 Compositions and methods for treating amyloidosis using sulphonate derivatives
09/02/2009CN101519439A Freezeproof polypeptide, synthesis, composition containing same and application thereof
09/02/2009CN101518650A Combination of a DPP IV inhibitor and a cardiovascular compound
09/02/2009CN101518639A Drug for treating acne
09/02/2009CN101518620A Chinese medicinal preparation for treating alopecia areata
09/02/2009CN101518614A Chinese patent medicine for treating chloasma
09/02/2009CN101518608A Anti-candidiasis albrican cream and preparation method thereof
09/02/2009CN101518602A Anti-herpes zoster traditional Chinese medical composition and preparation method thereof
09/02/2009CN101518601A Anti-eczema traditional Chinese medical composition and preparation method thereof
09/02/2009CN101518600A Chinese medicinal composition for treating bacterial or fungal dermatosis and preparation method thereof
09/02/2009CN101518596A Pharmaceutical composition for curing thermal damage of mammal or human and preparation method thereof
09/02/2009CN101518580A Pharmaceutical composition for clearing heat and releasing toxin as well as preparation method and application thereof
09/02/2009CN101518578A Powder for curing dermatophytosis and preparation method thereof
09/02/2009CN101518569A Human sterilizing liquid containing majoram oil and production method thereof
09/02/2009CN101518554A Oral medicinal preparation of hairy holly root total aglycon, preparation method and application thereof
09/02/2009CN101518544A Quickly-effective beriberi powder
09/02/2009CN100534997C C-aryl glucoside SGLT2 inhibitors and method
09/02/2009CN100534991C Heterocyclic inhibitors of ERK 2 and uses thereof
09/02/2009CN100534988C 2-arylimino-2,3-dihydrothiazole derivatives, methods for preparing them and therapeutic use thereof
09/02/2009CN100534981C 2-propylidene-19-nor-vitamin d compounds
09/02/2009CN100534446C Oral skin care composition
09/01/2009US7582756 3-(4-amidopyrrol-2-ylmethylidene)-2-indolinone derivatives as protein kinase inhibitors
09/01/2009US7582734 natural ligand for the orphan G-Protein Coupled Receptor (GPCR) ChemerinR and uses thereof in diagnosis and immuno therapy of a disease; monoclonal antibody; chemiattractant proteins; useful for the diagnosis and treatment of a disease or disorder related to the dysregulation of GPCR signaling
09/01/2009US7582660 2-thio-substituted imidazole derivatives and their use in pharmaceutics
09/01/2009US7582657 Vanilloid receptor ligands and their use in treatments
09/01/2009US7582644 Pyrimidyl sulphone amide derivatives as chemokine receptor modulators
09/01/2009US7582642 4-{9-Isopropyl-6-[(pyridin-3-ylmethyl)-amino]-9H-purin-2-ylamino}-2-methyl-hexan-3-ol;antiproliferative agents; viricides; alopecia; strokes; central nervous system diorders; neurodegenerative diseases; antidiabetic agents; mitosis; cyclin dependent kinase inhibitors; protein kinase inhibitors
09/01/2009US7582445 Anti-interferon-α antibodies
09/01/2009US7582440 Imaging, diagnosis and treatment of disease
09/01/2009US7582437 Adaptor protein that binds to mammalian toll-like receptor 3, and gene thereof
09/01/2009US7582317 Food supplements comprising, as a health component, sargahydroquinoic acid or derivative thereof
09/01/2009US7582313 Methods of organ regeneration using Hox 11-expressing pluripotent cells
09/01/2009US7582287 Method for treating cervical cancer
09/01/2009CA2432428C Quinazoline derivatives, pharmaceutical compositions containing these compounds, their use and processes for preparing them
09/01/2009CA2421761C Crab apple fruit polyphenol and production process thereof
09/01/2009CA2210812C T-cell affecting peptides
08/2009
08/27/2009WO2009105647A1 Methods for the treatment of dermatological disorders
08/27/2009WO2009105294A2 Topical compositions and methods for whitening skin
08/27/2009WO2009103959A2 Medicament
08/27/2009WO2009103816A1 Method for treatment of photosensitivity and phototoxicity
08/27/2009WO2009103754A2 Novel use of 3,3'-diindolylmethane
08/27/2009WO2009103501A1 Means and methods for controlling commensales
08/27/2009WO2009103500A1 Means and methods for controlling commensales
08/27/2009WO2009103427A2 Use of 3-(4-hydroxy-3-methoxyphenyl)-1(4-hydroxyphenyl)-propane-1-on against hyperpigmentation
08/27/2009WO2009103312A1 Ezrin, serpin b5, peroxiredoxin-2 and heat shock protein beta-1 as autoantigens for psoriasis and poststreptococcal diseases
08/27/2009WO2009103123A1 Dendrimeric enzyme inhibitors
08/27/2009WO2009086439A3 2-methylene-(20s,25s)-19,26-dinor-vitamin d analogs
08/27/2009WO2009086438A3 2-methylene-(20s,25r)-19,26-dinor-vitamin d analogs
08/27/2009WO2007143231A3 Methods of treating pain and inflammation in neuronal tissue using il-31 antagonists
08/27/2009US20090217392 Anti- integrin antibodies, compositions, methods and uses
08/27/2009US20090215995 isolated nucleic acids encoding B7-related polypeptides, including BSL3, which modulate cells that are important for immune and inflammatory responses, such as T-cells
08/27/2009US20090215902 Methods for the treatment of dermatological disorders
08/27/2009US20090215887 5-hydroxy-2-methyl-4h-pyran-4-one esters as novel tyrosinase inhibitors
08/27/2009US20090215884 Method for wound healing
08/27/2009US20090215851 Method of Preparing a Porphyrin Derivative, a Porphyrin Derivative, Use of Said Porphyrin derivative and a pharmaceutical composition containing said porphyrin derivative
08/27/2009US20090215849 High stability aqueous gels comprising metronidazole and methods for the preparation thereof
08/27/2009US20090215739 Chemical method of making a suspension, emulsion or dispersion of pyrithione particles
08/27/2009US20090215736 inhibitors of apoptosis and IL-1 beta secretion; mediate cell apoptosis and inflammation; good cell penetration and pharmacokinetic properties; [3S/R(2S)]3-[2-(Carbazol-9-yl-2-oxo-ethyl)-pentanoylamino]-5-fluoro-4-oxo-pentanoic acid
08/27/2009US20090215707 Compound having cyclic structure and use thereof
08/27/2009US20090215702 Uv-Induced Dermatitis Inhibitor and Atopic Dermatitis Inhibitor
08/27/2009US20090215690 Dickkopf1 (Dkk1) is a dual function protein demonstrates a mechanism for the coordination of cell migration and antagonism of Wnt/ beta -catenin signaling during developmental and pathological processes; finding therapeutic anticarcinogenic agent for breast cancer
08/27/2009US20090215672 Cys-Rich, Cell Surface Glycoproteins
08/27/2009US20090215164 Recombinant gene of adenovirus vector and p53 gene for treating proliferative diseases
08/27/2009US20090214666 Chitin microparticles and their medical uses
08/27/2009US20090214628 Methods and compositions for treatment of skin
08/27/2009US20090214622 Nanoporous Membrane and Method of Preparation Thereof
08/27/2009US20090214565 Anti-Interferon Alpha Monoclonal Antibodies and Methods For Use
08/27/2009US20090214549 Antigenic Epitopes Of Inteleukin-21, Related Antibodies And Their Use In Medical Field
08/27/2009US20090214512 Methods of treating skin disease, scalp disease, sensitive skin or suppressing hair loss with microbubble washing compositions
08/27/2009US20090214504 Methods and Compositions for Topical Treatment of Medical Conditions Including Wounds and Inflammation
08/27/2009US20090214460 Composition Comprising a Monomer Compound Exhibiting an Optical Property, Method Making Use of Said Composition, a Monomer Compound and a Polymer Containing Said Monomer Compound and the Use Thereof
08/27/2009DE202008005278U1 Hautschutzzusammensetzung Skin-protective composition
08/27/2009CA2753021A1 Medicament
08/27/2009CA2716509A1 Method for treatment of photosensitivity and phototoxicity
08/27/2009CA2716255A1 Cosmetic and dermatological formulations of mntf peptides
08/27/2009CA2713555A1 Topical compositions and methods for whitening skin